$74.610
-0.746 (-1.00%)收盘时
RDNT 资讯
RDNT 事件
RadNet Reports Q2 Revenue of $622.7M, Beating Expectations
Reports Q2 revenue $622.7M, consensus $609.33M. Dr. Howard Berger, President and Chief Executive Officer of RadNet, commented, "The Imaging Center and Digital Health reportable operating segments continue to demonstrate strong growth and achieve record quarterly results. In the second quarter of 2026, Total Company Revenue grew 25.0% and Digital Health segment Revenue increased 56.5% from last year's same quarter. Growth was driven by strong increases in aggregate and same center procedural volumes, the contribution from recent acquisitions, a continuing shift in procedural volumes towards advanced imaging and incremental Digital Health sales and licenses of Enterprise Imaging and AI solutions."
RadNet Subsidiary DeepHealth Receives FDA 510(k) Clearance
DeepHealth, a wholly owned subsidiary of RadNet, last night announced FDA 510(k) clearance for DeepHealth Breast Ultrasound, an AI-powered solution that it says "brings greater standardization, clinical accuracy and efficiency to breast ultrasound imaging." The company added: "DeepHealth Breast Ultrasound automates lesion detection, characterization and reporting, streamlining sonographer and radiologist workflows in one intelligent experience. Together with its AI-powered mammography solutions, the expanded DeepHealth breast platform is the most comprehensive in the industry."
DeepHealth Receives FDA Approval for New Breast Imaging Features
DeepHealth, a wholly owned subsidiary of RadNet, announces it has received FDA 510(k) clearances for two new Breast Suite functionalities: Breast Arterial Calcification Assessment, a tool applied to standard screening mammograms that automatically identifies breast arterial calcifications, a potential early indicator of cardiovascular disease; Prior exam integration into ProFound Pro, which enables automatic processing of prior and current studies to track prior lesions and distinguish new lesions, with the goal of improving cancer detection rates and reducing recalls. ProFound Pro with prior exam integration will be brought to market as Mammo Dx. The two additions reinforce Breast Suite as the industry's most comprehensive end-to-end breast imaging AI suite-a modular, interoperable portfolio of applications addressing real-world clinical needs across breast cancer screening and diagnostic pathways. Both newly FDA cleared functionalities are now commercially available in the United States.
RadNet Shares Drop 8.2% to $51.89
RadNet is down -8.2%, or -$4.62 to $51.89.
RadNet Forms Joint Venture with Saint Alphonsus Health System
RadNet announced the formation of a joint venture with Saint Alphonsus Health System through the acquisition of a majority equity position in Intermountain Medical Imaging, the owner of five outpatient multi-modality imaging centers in Boise, Idaho. The Idaho-based joint venture with Saint Alphonsus Health System, which is part of Trinity Health, operates three multimodality outpatient imaging centers in Meridian and Eagle, as well as facilities at two Saint Alphonsus medical centers. The existing contracted radiology practice for the joint venture, Gem State Radiology, will continue providing professional radiology services to the five locations through its network of nearly 30 radiologists. RadNet will assume management of the operations for each of the five locations. The centers currently offer a mix of MRI, CT, PET/CT, mammography, ultrasound, X-ray and other related procedures. The new joint venture is projected to generate approximately $30M in annual revenue for RadNet.
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。